Travere Prices Upsized $475.0 Million Convertible Senior Notes Offering to Refinance 2029 Convertible Notes

Key Takeaway: Travere Therapeutics has announced an upsized offering of $475 million in convertible senior notes. This move is aimed at refinancing existing convertible notes due in 2029. The offering reflects the company's strategy to manage its debt and optimize its capital structure.